Results 121 to 130 of about 37,549 (151)

A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea. [PDF]

Open Forum Infect Dis
Mok J, Seo H, Cho Y, Lee T, Kim SH, Park HK, Oh JY, Shim TS.   +7 more
europepmc   +1 more source

Efficacy and safety of an all-oral delamanid-containing regimen in the treatment of multidrug-resistant pulmonary tuberculosis complicated by extrapulmonary tuberculosis: Four case reports and review of the literature. [PDF]

J Clin Tuberc Other Mycobact Dis
Hu X, Cheng C, Jin Q, Jin W, Dong Q, Wu F, Hu F, Li Y, Wang L, Lu L, Xu Q, Du J.   +11 more
europepmc   +1 more source

Correction: Unraveling the Secrets Behind the Multidrug-Resistant Tuberculosis Treatment Outcome in Chronic Renal Failure Patients Requiring Hemodialysis: A Systematic Review. [PDF]

Cureus
Hernandez GN, Seffah K, Zaman MA, Awais N, Satnarine T, Haq A, Patel D, Gutlapalli SD, Ahmed A, Khan S.   +9 more
europepmc   +1 more source

Why solutions to antimicrobial resistance are urgently needed.

Dis Model Mech
Mostowy S, Duncan KR.
europepmc   +1 more source

Optimizing tuberculosis infection screening strategies for people living with HIV in Thailand: a cost-effectiveness analysis. [PDF]

BMC Public Health
Chumpa N, Ohata PJ, Suwanpimolkul G.
europepmc   +1 more source

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan. [PDF]

Clin Infect Dis
Sinha A, Klebe R, Rekart ML, Alvarez JL, Skrahina A, Yatskevich N, Solodovnikova V, Viatushka D, Parpieva N, Safaev K, Liverko I, Tigay Z, Moe S, Khristusev A, Allamuratova S, Mirzabaev S, Achilov M, Samieva N, Lachenal N, Merle CS, Sall FB, Restrepo CG, Tan C, Sitali N, Saunders MJ.   +24 more
europepmc   +1 more source